Saundra Jain, MA, PsyD, LPC, shares strategies for maintaining social connections in the age of COVID-19 and explains the importance of social connectedness.
Saundra Jain, MA, PsyD, LPC, shares strategies for maintaining social connections in the age of COVID-19 and explains the importance of social connectedness.
In this video, Michael Thase, MD, of the University of Pennsylvania discusses the management of treatment-resistant depression during the COVID-19 pandemic.
In this video, Michael Thase, MD, of the University of Pennsylvania discusses the management of treatment-resistant depression during the COVID-19 pandemic.
Psych Congress Steering Committee member and psychiatrist Rakesh Jain, MD, MPH, discusses reflections he has had during the COVID-19 pandemic about his 33 years of treating major depressive disorder.
Psych Congress Steering Committee member and psychiatrist Rakesh Jain, MD, MPH, discusses reflections he has had during the COVID-19 pandemic about his 33 years of treating major depressive disorder.
In this video, Vladimir Maletic, MD, MS, discusses diet and nutrition challenges that patients with major depressive disorder may be experiencing during the COVID-19 pandemic.
In this video, Vladimir Maletic, MD, MS, discusses diet and nutrition challenges that patients with major depressive disorder may be experiencing during the COVID-19 pandemic.
Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discusses practices to strengthen well-being and wellness during the COVID-19 epidemic.
Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discusses practices to strengthen well-being and wellness during the COVID-19 epidemic.
Join Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, a body scan meditation, a type of meditation which promotes greater awareness of the physical body.
Join Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, a body scan meditation, a type of meditation which promotes greater awareness of the physical body.
Psych Congress cochair Charles Raison, MD, speaks about how the COVID-19 pandemic has affected him personally and professionally and its impacts on clinical research studies and funding sources.
Psych Congress cochair Charles Raison, MD, speaks about how the COVID-19 pandemic has affected him personally and professionally and its impacts on clinical research studies and funding sources.
Psych Congress Steering Committee member Edward Kaftarian, MD, talks about the ramifications of the COVID-19 pandemic and his learnings from the crisis.
Psych Congress Steering Committee member Edward Kaftarian, MD, talks about the ramifications of the COVID-19 pandemic and his learnings from the crisis.
Psych Congress Steering Committee member Arwen Podesta, MD, ABPN, FASAM, ABIHM, discusses changes she has experienced during the COVID-19 pandemic, including the expansion of telehealth.
Psych Congress Steering Committee member Arwen Podesta, MD, ABPN, FASAM, ABIHM, discusses changes she has experienced during the COVID-19 pandemic, including the expansion of telehealth.
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
